# Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma

> **NCT00631137** · NA · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 1 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Musculoskeletal Complications

## Interventions

- **DRUG:** testosterone gel applied to skin
- **DIETARY_SUPPLEMENT:** whey powder protein

## Key facts

- **NCT ID:** NCT00631137
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated due to low accrual.
- **Last updated:** 2018-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631137, "Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00631137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*